LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC ADENOCARCINOMA
Clinical trials for LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail of drugs shows promise for tough stomach cancer
Disease control Recruiting nowThis Phase 2 trial is testing several new drug combinations in people with advanced stomach or gastroesophageal junction cancer that cannot be removed by surgery or has spread. The study aims to see if these combinations can shrink tumors and keep them from growing for at least 6…
Matched conditions: LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug cocktail targets Hard-to-Treat stomach cancer
Disease control Recruiting nowThis Phase 2 trial is testing whether a new targeted drug called SHR2554, taken as a tablet, can be safely combined with other anti-cancer injections to treat advanced stomach or gastroesophageal junction cancer. The study will enroll 351 adults whose cancer has spread or cannot …
Matched conditions: LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 15:42 UTC